TERMS (Thalidomide Education and Risk Management System) time-series data analyses and patients’ awareness level. - Can change point detection methods be applied? -
- In: Posters
- At: Dublin (Ireland) (2013)
- Type: Poster
- By: KUBO, Teruyoshi (Osaka University, Pharmacy, Osaka, Japan)
- Co-author(s): Takagi, Tatsuya (Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan)
Shirakuni, Yuko (Osaka University, Osaka, Japan)
Kawashita, Norihito (Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan)
Hattori, Chizuko (Osaka University, Osaka, Japan)
Nasu, Masao (Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan) - Abstract:
I. Background
In October 2008, thalidomide was reapproved as a treatment of multiple myeloma (MM). Since thalidomide caused one of the worst drug disasters in 1950s - 1960s, Thalidomide Education and Risk Management System (TERMS)TM was developed. Thalidomide has been marketed and prescribed under TERMS.
TERMS has been revised twice, considering .. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 28 September 2023